drugset
Drugs / Expanded autologous ASCs
last change Jul 2012 re-read 3 minutes ago

Expanded autologous ASCs

also known as Expanded autologous Adipose-derived adult Stroma/Stem cells

Cell therapy

Developed for
peripheral vascular disease
Investigated by
Centre National de la Recherche Scientifique, France · Clinical Research Center, Toulouse · French Blood Establishment · University Hospital, Toulouse

Trials 1

today NCT01211028 · Ph 1/2
2009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT01211028 Jan 2009 → Jul 2012 peripheral vascular disease University Hospital, Toulouse Completed No outcome recorded

Evidence & citations 4 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Expanded autologous ASCs ClinicalTrials.gov intervention name — accepted as the source's own label NCT01211028 ↗
Known as Expanded autologous Adipose-derived adult Stroma/Stem cells “Expanded autologous Adipose-derived adult Stroma/Stem cells” NCT01211028 ↗
Modality Cell therapy “Expanded autologous ASCs (Adipose Stroma/Stem Cells)” NCT01211028 ↗
Route Intramuscular “administered intramuscularly” NCT01211028 ↗